Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
An interim analysis from the REVEAL study provides insights into patient profiles and early responses in systemic lupus erythematosus patients initiating treatment with anifrolumab. This multicenter observational study aims to enhance understanding of treatment effects in this complex disease.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.